- Home
- XRTX vs ISPC Comparison
XRTX vs ISPC Comparison
Compare XRTX & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- ISPC
- Stock Information
- Founded
- XRTX 2011
- ISPC 2009
- Country
- XRTX Canada
- ISPC United States
- Employees
- XRTX N/A
- ISPC N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- ISPC Precision Instruments
- Sector
- XRTX Health Care
- ISPC Health Care
- Exchange
- XRTX Nasdaq
- ISPC Nasdaq
- Market Cap
- XRTX 3.0M
- ISPC 3.1M
- IPO Year
- XRTX N/A
- ISPC 2021
- Fundamental
- Price
- XRTX $1.08
- ISPC $1.25
- Analyst Decision
- XRTX
- ISPC
- Analyst Count
- XRTX 0
- ISPC 0
- Target Price
- XRTX N/A
- ISPC N/A
- AVG Volume (30 Days)
- XRTX 44.3K
- ISPC 141.4K
- Earning Date
- XRTX 05-16-2025
- ISPC 04-14-2025
- Dividend Yield
- XRTX N/A
- ISPC N/A
- EPS Growth
- XRTX N/A
- ISPC N/A
- EPS
- XRTX N/A
- ISPC N/A
- Revenue
- XRTX N/A
- ISPC $9,291,115.00
- Revenue This Year
- XRTX N/A
- ISPC $35.93
- Revenue Next Year
- XRTX N/A
- ISPC N/A
- P/E Ratio
- XRTX N/A
- ISPC N/A
- Revenue Growth
- XRTX N/A
- ISPC N/A
- 52 Week Low
- XRTX $0.80
- ISPC $1.02
- 52 Week High
- XRTX $3.24
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- XRTX 59.65
- ISPC 47.69
- Support Level
- XRTX $0.82
- ISPC $1.15
- Resistance Level
- XRTX $1.13
- ISPC $1.23
- Average True Range (ATR)
- XRTX 0.10
- ISPC 0.16
- MACD
- XRTX 0.03
- ISPC 0.02
- Stochastic Oscillator
- XRTX 71.65
- ISPC 28.67
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.